Search the Archive

Medicine: ImClone Cancer Drug #704824

CNN Evening News for Friday, Jul 05, 2002
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Aaron Brown) Report introduced.

(New York: Allan Chernoff) The controversy over the FDA (Food and Drug Administration)'s decision not to approve the ImClone cancer drug C225 examined; details given about the clinical trials. [On June 25, Martha STEWART†- says the insider trading case will be resolved soon.] [Cancer patient & husband Rachel & Phil HIGHTOWER†- express frustration about not being able to get to drugs that can help.] [May 5, former ImClone CEO Sam WAKSAL†- says the drug will be on the market next year.] [Johns Hopkins Kimmel Cancer Center Dr. Manuel HIDALGO†- says few drugs pass all the tests & trials.] The initial trial results for C225 discussed.

Reporter(s):
Brown, Aaron;
Chernoff, Allan
Duration:
00:05:30

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.